U.S. Markets close in 4 hrs 55 mins

Eurofins Scientific SE (ERF.PA)

Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
66.31-1.75 (-2.57%)
As of 4:50PM CET. Market open.
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close68.06
Open68.08
Bid0.00 x 0
Ask0.00 x 0
Day's Range66.08 - 68.85
52 Week Range39.30 - 75.40
Volume169,485
Avg. Volume314,905
Market Cap12.648B
Beta (5Y Monthly)N/A
PE Ratio (TTM)66.31
EPS (TTM)N/A
Earnings DateMar 01, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est508.91
  • Eurofins Viracor Diagnostics Launches Combined Test For COVID-19, Influenza, And RSV As The Flu Season Approaches
    PR Newswire

    Eurofins Viracor Diagnostics Launches Combined Test For COVID-19, Influenza, And RSV As The Flu Season Approaches

    Eurofins Viracor, a leading infectious disease testing laboratory for more than 35 years, announces the launch of several combined tests which detect COVID-19, influenza A/B, and respiratory syncytial virus (RSV). The combined SARS-CoV-2 Plus Flu A/B and RSV tests are intended for the qualitative detection of SARS-CoV-2 and the quantitative detection of Influenza A, Influenza B, and RSV.

  • Eurofins Transplant Diagnostics Introduces TruGraf Liver At AASLD - The Liver Meeting
    PR Newswire

    Eurofins Transplant Diagnostics Introduces TruGraf Liver At AASLD - The Liver Meeting

    Transplant Genomics, Inc. ("TGI") a member of Eurofins Transplant Diagnostics, is excited to introduce TruGraf Liver, the only non-invasive blood-based test to assist in lowering immunosuppression in liver transplant patients, at The Liver Meeting Digital Experience ("The Liver Meeting"). The Liver Meeting is the annual meeting of the American Association for the Study of Liver Diseases, being held online November 13-16, 2020. In continuation of Eurofins Transplant's commitment to improving organ transplant outcomes worldwide, TruGraf Liver follows TruGraf®, the only non-invasive kidney rejection test reimbursed by CMS for the surveillance of "silent" sub-clinical acute rejection in patients with stable renal function.

  • Eurofins CDMO Announces Expansion of Drug Product Capabilities in Canada
    Business Wire

    Eurofins CDMO Announces Expansion of Drug Product Capabilities in Canada

    Eurofins CDMO announces the strategic expansion of its existing Drug Product operation capabilities with the early 2020 completion of its new Drug Product development and cGMP manufacturing facility, located in Mississauga, Canada.